“Focus Malaysia” Business News- 17 July 2017
The pharmaceutical industry is not showing signs of slowing down. In Malaysia alone, the revenue from the industry is worth RM12 bil annually. The positive development of the industry benefited many companies in the SME category.
For example, BioCare Group Sdn Bhd, which is a producer of respiratory problem solutions, has been enjoying growing demand for its metered dose inhaler (MDI).
Founded by Kedah-born, Saravanan Govindasamy, the company morphed from being a supplier of generic pharmaceutical items to go into product development.
“While I was working for a pharmaceutical company, I had to deal with hospitals to bring in imported MDI items. The MDI product is used as a lifesaving drug for asthma patients. That was how I know that the demand for that particular product was much needed in the country,” Saravanan, who is its group managing director, tells FocusM…Back to Events